Related stories
Summit Therapeutics Shares Fall 20% After FDA Rejection
Summit Therapeutics shares fell 20% overnight after an FDA rejection over the weekend. Capricor Therapeutics investors are awaiting a Nov. 22 FDA decision on Deramiocel.
M impact | EQUITY | Nov 16, 2026, 01:49 AM UTC
Thai Polycons Posts Quarterly Loss of 621.65 Million Baht
M impact | EQUITY | Nov 16, 2026, 01:31 AM UTC
Advantest Shares Fall 9.0%, Lasertec Drops 9.4%, Ibiden Down 7.1%
L impact | EQUITY | Nov 16, 2026, 01:30 AM UTC
Asian session market picture: S&P 500 -0.18%, Nasdaq 100 -0.46%; USD/JPY +0.02%, WTI -0.4%, 9988 leads volume
Asian session market picture. US index futures: S and P futures is down 0.18 percent, Nasdaq futures is down 0.46 percent, Dow futures is down 0.1 percent and Russell futures is do
M impact | EQUITY | Nov 16, 2026, 01:30 AM UTC
Nikkei Falls 0.99% and Kospi Drops 0.33% as Asian Shares Weaken
The Topix lost 0.17%, while Hang Seng futures rose 0.6%. MSCI’s gauge of Asian shares inched lower.
M impact | EQUITY | Nov 16, 2026, 01:24 AM UTC
Therma Power Acquires TPEC Holdings
Aboitiz Power announced the acquisition of TPEC Holdings by Therma Power.
M impact | EQUITY | Nov 16, 2026, 01:23 AM UTC